A critical review of mTOR inhibitors and epilepsy: from basic science to clinical trials
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A critical review of mTOR inhibitors and epilepsy: from basic science to clinical trials
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 13, Issue 6, Pages 657-669
Publisher
Informa UK Limited
Online
2013-06-06
DOI
10.1586/ern.13.48
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rapamycin Prevents Seizures After Depletion of STRADA in a Rare Neurodevelopmental Disorder
- (2013) W. E. Parker et al. Science Translational Medicine
- Rapamycin suppresses the recurrent excitatory circuits of dentate gyrus in a mouse model of temporal lobe epilepsy
- (2012) Haiyun Tang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Deconvoluting mTOR biology
- (2012) Jason D. Weber et al. CELL CYCLE
- Mammalian Target of Rapamycin (mTOR) Inhibition: Potential for Antiseizure, Antiepileptogenic, and Epileptostatic Therapy
- (2012) Robin C. C. Ryther et al. Current Neurology and Neuroscience Reports
- Finding a better drug for epilepsy: The mTOR pathway as an antiepileptogenic target
- (2012) Aristea S. Galanopoulou et al. EPILEPSIA
- Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation
- (2012) Erwin A. van Vliet et al. EPILEPSIA
- Rapamycin has age-, treatment paradigm-, and model-specific anticonvulsant effects and modulates neuropeptide Y expression in rats
- (2012) Tamar Chachua et al. EPILEPSIA
- The mTOR pathway is activated in glial cells in mesial temporal sclerosis
- (2012) Alexander A. Sosunov et al. EPILEPSIA
- Pentylenetetrazole-induced seizures cause acute, but not chronic, mTOR pathway activation in rat
- (2012) Bo Zhang et al. EPILEPSIA
- The differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex
- (2012) Sharon W. Way et al. HUMAN MOLECULAR GENETICS
- Arrest of Myelination and Reduced Axon Growth When Schwann Cells Lack mTOR
- (2012) D. L. Sherman et al. JOURNAL OF NEUROSCIENCE
- Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
- (2012) David Neal Franz et al. LANCET
- De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly
- (2012) Jeong Ho Lee et al. NATURE GENETICS
- Excessive Activation of mTOR in Postnatally Generated Granule Cells Is Sufficient to Cause Epilepsy
- (2012) Raymund Y.K. Pun et al. NEURON
- Somatic Activation of AKT3 Causes Hemispheric Developmental Brain Malformations
- (2012) Annapurna Poduri et al. NEURON
- mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy
- (2012) Emilio Russo et al. NEUROPHARMACOLOGY
- Rapamycin down-regulates KCC2 expression and increases seizure susceptibility to convulsants in immature rats
- (2012) X. Huang et al. NEUROSCIENCE
- Post-treatment with rapamycin does not prevent epileptogenesis in the amygdala stimulation model of temporal lobe epilepsy
- (2012) Anna Sliwa et al. NEUROSCIENCE LETTERS
- The Interaction between Early Life Epilepsy and Autistic-Like Behavioral Consequences: A Role for the Mammalian Target of Rapamycin (mTOR) Pathway
- (2012) Delia M. Talos et al. PLoS One
- Mapping the Spatio-Temporal Pattern of the Mammalian Target of Rapamycin (mTOR) Activation in Temporal Lobe Epilepsy
- (2012) Long-Ze Sha et al. PLoS One
- The mTOR Inhibitor Rapamycin Has Limited Acute Anticonvulsant Effects in Mice
- (2012) Adam L. Hartman et al. PLoS One
- mTOR signaling in disease
- (2011) Eva Dazert et al. CURRENT OPINION IN CELL BIOLOGY
- Is there a critical period for mossy fiber sprouting in a mouse model of temporal lobe epilepsy?
- (2011) Felicia H. Lew et al. EPILEPSIA
- Validation of the rat model of cryptogenic infantile spasms
- (2011) Tamar Chachua et al. EPILEPSIA
- Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma
- (2011) Wolfgang Löscher et al. EPILEPSIA
- Effective everolimus treatment of inoperable, life-threatening subependymal giant cell astrocytoma and intractable epilepsy in a patient with tuberous sclerosis complex
- (2011) Marta Perek-Polnik et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Frontier of Epilepsy Research - mTOR signaling pathway
- (2011) Chang-Hoon Cho EXPERIMENTAL AND MOLECULAR MEDICINE
- Combination Therapy Targeting Akt and Mammalian Target of Rapamycin Improves Functional Outcome after Controlled Cortical Impact in Mice
- (2011) Juyeon Park et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Rapamycin Suppresses Mossy Fiber Sprouting But Not Seizure Frequency in a Mouse Model of Temporal Lobe Epilepsy
- (2011) P. S. Buckmaster et al. JOURNAL OF NEUROSCIENCE
- Mechanisms of epileptogenesis and potential treatment targets
- (2011) Asla Pitkänen et al. LANCET NEUROLOGY
- Ridaforolimus (AP23573; MK-8669), a Potent mTOR Inhibitor, Has Broad Antitumor Activity and Can Be Optimally Administered Using Intermittent Dosing Regimens
- (2011) V. M. Rivera et al. MOLECULAR CANCER THERAPEUTICS
- Fighting neurodegeneration with rapamycin: mechanistic insights
- (2011) Jordi Bové et al. NATURE REVIEWS NEUROSCIENCE
- A pulse rapamycin therapy for infantile spasms and associated cognitive decline
- (2011) Emmanuel Raffo et al. NEUROBIOLOGY OF DISEASE
- Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin
- (2011) Robert P. Carson et al. NEUROBIOLOGY OF DISEASE
- Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis
- (2011) Sharon S. McDaniel et al. NEUROSCIENCE LETTERS
- Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex
- (2011) J. Goto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- mTOR: A pathogenic signaling pathway in developmental brain malformations
- (2011) Peter B. Crino TRENDS IN MOLECULAR MEDICINE
- Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of Tuberous Sclerosis Complex
- (2010) L.-H. Zeng et al. HUMAN MOLECULAR GENETICS
- STRADα deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice
- (2010) Ksenia A. Orlova et al. JOURNAL OF CLINICAL INVESTIGATION
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy
- (2010) Xiaoxing Huang et al. NEUROBIOLOGY OF DISEASE
- Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis
- (2010) Darcy A. Krueger et al. NEW ENGLAND JOURNAL OF MEDICINE
- The tuberous sclerosis complex
- (2009) Ksenia A. Orlova et al. Annals of the New York Academy of Sciences
- Pi3K-mTOR Signaling and AMOG Expression in Epilepsy-associated Glioneuronal Tumors
- (2009) Karin Boer et al. BRAIN PATHOLOGY
- Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia
- (2009) M. C. Ljungberg et al. Disease Models & Mechanisms
- The natural history of epilepsy in tuberous sclerosis complex
- (2009) Catherine J. Chu-Shore et al. EPILEPSIA
- Focal brain malformations: Seizures, signaling, sequencing
- (2009) Peter B. Crino EPILEPSIA
- Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies
- (2009) Michael Wong EPILEPSIA
- Rapamycin Reduces Seizure Frequency in Tuberous Sclerosis Complex
- (2009) Jennifer Muncy et al. JOURNAL OF CHILD NEUROLOGY
- Inhibition of the Mammalian Target of Rapamycin Signaling Pathway Suppresses Dentate Granule Cell Axon Sprouting in a Rodent Model of Temporal Lobe Epilepsy
- (2009) P. S. Buckmaster et al. JOURNAL OF NEUROSCIENCE
- The Mammalian Target of Rapamycin Signaling Pathway Mediates Epileptogenesis in a Model of Temporal Lobe Epilepsy
- (2009) L.-H. Zeng et al. JOURNAL OF NEUROSCIENCE
- Pharmacological Inhibition of mTORC1 Suppresses Anatomical, Cellular, and Behavioral Abnormalities in Neural-Specific Pten Knock-Out Mice
- (2009) J. Zhou et al. JOURNAL OF NEUROSCIENCE
- Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex
- (2008) Ling-Hui Zeng et al. ANNALS OF NEUROLOGY
- Clinical Presentation and Diagnosis of Tuberous Sclerosis Complex in Infancy
- (2008) Anita N. Datta et al. JOURNAL OF CHILD NEUROLOGY
- Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function
- (2008) L. Meikle et al. JOURNAL OF NEUROSCIENCE
- Reversal of learning deficits in a Tsc2 +/− mouse model of tuberous sclerosis
- (2008) Dan Ehninger et al. NATURE MEDICINE
- Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
- (2008) John J. Bissler et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started